7:00 am Stemline Therapeutics announces FDA acceptance of IND for SL-701, a synthetic multi-peptide vaccine targeting glioma brain tumors
moreView todays social media effects on STMLView the latest stocks trending across Twitter. Click to view dashboardSee who Stemline is hiring next, click here to view […]